Today, our future has never looked brighter. Diversity and inclusion are top priorities for CSL.Innovation spans across our organization with a focus on solving patients' unmet needs.Our exceptionally strong performance is a result of the focused execution of our strategy.Our interim dividend for 2020 was US$0.95 per share, up 12%.CSL is a global biotech leader. In 2005, PCCW re-entered the mobile network operator business by acquiring SUNDAY and setting up a new brand "PCCW Mobile". In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994. See how we're Driven by Our Promise.Join us and make history with the brightest, most passionate people from every discipline.Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.We manufacture products to treat a number of rare diseases.We also aim to make sure that nothing holds you back from getting the therapies you need.Help us deliver on our promise to save lives and protect the health of people.We offer a variety of support programs and activities for the patients we serve.Meet our Global Leadership Group. CSL provides the publishing of the Thailand YellowPages through its subsidiary, Teleinfo Media Public Company Limited (TMC). CSL Behring operates the plasma collection network CSL Plasma. In 2014, HKT (a member of PCCW Group) acquired CSL New World Mobility and its subsidiaries such as CSL Limited and New World Mobility.
Today, we compete on the global stage as one of the largest and fastest-growing protein-based biotechnology businesses and a leading provider of in-licensed vaccines.We deliver on our promise to patients.Innovation spans across our organization with a focus on solving patients' unmet needs.Our interim dividend for 2020 was US$0.95 per share, up 12%.Innovation has been in the DNA of CSL since our beginning in 1916 and is at the core of everything we do today.Join a global biotechnology leader. With an unwavering focus on our promise to patients – to deliver life-saving and life-improving therapies that help many thousands of people live full lives – it is our dedicated management and employees that drive our performance.Our product portfolio focuses on innovation in new productsVisit this page to see all of our current news releasesGet our latest news in your inboxDelve into our portfolio of new products, improved products and manufacturing expertise.Our Executive Board and management are committed to shareholder value.Seqirus opened in 2015 and is the second largest influenza company in the world.Innovation has been in the DNA of CSL since our beginning in 1916For 100 years, CSL has earned a reputation as a passionate yet responsible organization that is driven to care for patients and deliver on its commitments. CSL Behring is a member of the Australian CSL Group of companies. Audit report The audit report is contained in the attached Financial Report. The trademarks marked ® are registered by CSL Limited or its affiliates or subsidiaries in one or more jurisdictions, unless indicated otherwise. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health."
Find the latest CSL FPO (CSL.AX) stock quote, history, news and other vital information to help you with your stock trading and investing. CSL Limited Annual Report 2018 1 Driven by our promise, CSL is a global biotechnology leader which develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical
CSL Mobile Limited (Chinese: 香港移動通訊有限公司) is a Hong Kong telecommunications company, which operates mobile network brands of "csl", "1O1O" and "Club SIM".CSL is a subsidiary of Hong Kong Telecom (HKT) and was Hong Kong's first mobile communications operator established in 1983, and also the first network to launch the world’s first dual band 4G LTE network with DC-HSPA+. We develop and deliver innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions live full lives. A subsidiary of CSL Behring, CSL Plasma is the largest collector of human blood plasma in the world, sourcing plasma from hundreds of thousands of donors globally to produce a range of life-saving medicines for critically ill patients.Diversity and inclusion are top priorities for CSL Behring.A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.Read the latest news from CSL Behring.We work every day as if someone’s life depends on it, because it does.We collaborate with rare disease organizations to promote quality medical care and services.Get our latest Vita stories in your inboxSince then, CSL has acquired a number of companies.